Rafael Holdings, Inc.

  • Market Cap: N/A
  • Industry: Realty
  • ISIN: US75062E1064
USD
1.22
-0.03 (-2.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

36.35 k

Shareholding (Jan 2025)

FII

0.22%

Held by 9 FIIs

DII

94.22%

Held by 6 DIIs

Promoter

0.00%

How big is Rafael Holdings, Inc.?

22-Jun-2025

As of Jun 18, Rafael Holdings, Inc. has a market capitalization of 98.92 million, with net sales of 0.72 million and a net loss of 81.68 million over the last four quarters. As of Jul 24, the company reported shareholder's funds of 82.19 million and total assets of 96.83 million.

As of Jun 18, Rafael Holdings, Inc. has a market capitalization of 98.92 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 0.72 million for the latest four quarters. During the same period, the net profit was a loss of 81.68 million.<BR><BR>As of Jul 24, the balance sheet shows shareholder's funds of 82.19 million and total assets of 96.83 million.

Read More

What does Rafael Holdings, Inc. do?

22-Jun-2025

Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company focused on developing cancer therapies and also operates in the realty industry, with a market capitalization of approximately $98.92 million. As of January 2025, it reported net sales of $0 million and a net loss of $5 million.

Overview:<BR>Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company focused on developing therapies that exploit the metabolic differences between normal cells and cancer cells, and it operates in the Realty industry with a micro-cap market capitalization.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Jan 2025) <BR>Most recent Net Profit: -5 Million (Quarterly Results - Jan 2025) <BR>Market-cap: USD 98.92 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 4.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: -15.13% <BR>Price to Book: 1.23<BR><BR>Contact Details:<BR>Address: 520 Broad St, NEWARK NJ: 07102-3121 <BR>Tel: 1 973 4381000 <BR>Website: https://rafaelholdings.com

Read More

Who are in the management team of Rafael Holdings, Inc.?

22-Jun-2025

As of March 2022, the management team of Rafael Holdings, Inc. includes Howard Jonas as Chairman and CEO, Stephen Greenberg as Lead Independent Director, and Boris Pasche and Michael Weiss as Independent Directors.

As of March 2022, the management team of Rafael Holdings, Inc. includes Mr. Howard Jonas, who serves as the Chairman of the Board and Chief Executive Officer. Additionally, Mr. Stephen Greenberg is the Lead Independent Director, while Dr. Boris Pasche and Dr. Michael Weiss both hold the position of Independent Director.

Read More

Is Rafael Holdings, Inc. overvalued or undervalued?

25-Jun-2025

As of June 13, 2023, Rafael Holdings, Inc. is considered overvalued with a valuation grade of "does not qualify," reflected in its low P/E ratio of 4, negative EV to EBITDA of -3.54, and a significant decline in stock performance, indicating deteriorating investment appeal compared to peers.

As of 13 June 2023, the valuation grade for Rafael Holdings, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company appears to be overvalued, particularly given its P/E ratio of 4, which is substantially lower than peers like Five Point Holdings LLC at 6.72 and AMREP Corp. at 8.69. Additionally, Rafael's EV to EBITDA stands at -3.54, highlighting negative earnings potential compared to its peers.<BR><BR>Rafael's financial metrics further underscore its valuation concerns, with a ROE of 31.97% that, while seemingly positive, is overshadowed by a troubling ROCE of -62.16%. The PEG ratio of 0.01 suggests that the company's growth prospects are not being adequately reflected in its current price. Recent stock performance shows a 1-week decline of 17.50%, contrasting sharply with the S&P 500's minimal loss of 0.13%, reinforcing the notion that Rafael Holdings, Inc. is currently overvalued in the market.

Read More

Is Rafael Holdings, Inc. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, Rafael Holdings, Inc. has shifted to a bearish technical trend, with negative indicators across multiple analyses and underperformance compared to the S&P 500.

As of 4 September 2025, the technical trend for Rafael Holdings, Inc. has changed from mildly bullish to bearish. The weekly MACD is bearish, and moving averages are also indicating a bearish stance. The Bollinger Bands and Dow Theory are both showing mildly bearish signals on the weekly and monthly time frames. The KST is bearish on the weekly but mildly bullish on the monthly, while the OBV reflects a mildly bearish trend weekly and mildly bullish monthly.<BR><BR>In terms of performance, Rafael Holdings has underperformed the S&P 500 across multiple periods, with a year-to-date return of -0.41% compared to the S&P 500's 12.22%, and a one-year return of -1.01% versus 17.14%. Overall, the current technical stance is bearish, indicating weakness in the stock's performance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 47 Million ()

stock-summary
P/E

4.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-15.13%

stock-summary
Price to Book

0.59

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.86%
0%
-15.86%
6 Months
-23.75%
0%
-23.75%
1 Year
-32.01%
0%
-32.01%
2 Years
-31.63%
0%
-31.63%
3 Years
-35.45%
0%
-35.45%
4 Years
-76.87%
0%
-76.87%
5 Years
-94.6%
0%
-94.6%

Rafael Holdings, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-32.13%
EBIT Growth (5y)
-27.10%
EBIT to Interest (avg)
-24.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
9.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
13.31%
ROCE (avg)
0
ROE (avg)
5.94%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.39
EV to EBIT
-3.46
EV to EBITDA
-3.54
EV to Capital Employed
2.15
EV to Sales
50.44
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
-62.16%
ROE (Latest)
31.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jan 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 8 Schemes (5.56%)

Foreign Institutions

Held by 9 Foreign Institutions (0.22%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 300.00% vs 0.00% in Jan 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 22.64% vs 42.39% in Jan 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.40",
          "val2": "0.10",
          "chgp": "300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.90",
          "val2": "-3.50",
          "chgp": "-68.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "-2.00",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.10",
          "val2": "-5.30",
          "chgp": "22.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16,334.30%",
          "val2": "-46,610.40%",
          "chgp": "3,027.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jul'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jul 2024 is 100.00% vs -25.00% in Jul 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jul 2024 is -647.13% vs 93.81% in Jul 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jul'24",
        "Jul'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "0.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.50",
          "val2": "-15.00",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-58.90",
          "val2": "2.60",
          "chgp": "-2,365.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-65.00",
          "val2": "-8.70",
          "chgp": "-647.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20,040.80%",
          "val2": "-53,917.60%",
          "chgp": "3,387.68%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQstock-summary
Apr'25
Jan'25
Change(%)
Net Sales
0.40
0.10
300.00%
Operating Profit (PBDIT) excl Other Income
-5.90
-3.50
-68.57%
Interest
0.20
0.20
Exceptional Items
-1.00
-2.00
50.00%
Consolidate Net Profit
-4.10
-5.30
22.64%
Operating Profit Margin (Excl OI)
-16,334.30%
-46,610.40%
3,027.61%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2025 is 300.00% vs 0.00% in Jan 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 22.64% vs 42.39% in Jan 2025

Annual Results Snapshot (Consolidated) - Jul'24stock-summary
Jul'24
Jul'23
Change(%)
Net Sales
0.60
0.30
100.00%
Operating Profit (PBDIT) excl Other Income
-12.50
-15.00
16.67%
Interest
0.20
0.00
Exceptional Items
-58.90
2.60
-2,365.38%
Consolidate Net Profit
-65.00
-8.70
-647.13%
Operating Profit Margin (Excl OI)
-20,040.80%
-53,917.60%
3,387.68%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jul 2024 is 100.00% vs -25.00% in Jul 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jul 2024 is -647.13% vs 93.81% in Jul 2023

stock-summaryCompany CV
About Rafael Holdings, Inc. stock-summary
stock-summary
Rafael Holdings, Inc.
Realty
Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company. The Company is focused on developing and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. It also owns interests in certain commercial real estate assets. The Company conducts business as two operating segments, Pharmaceuticals and Real Estate.
Company Coordinates stock-summary
Company Details
520 Broad St , NEWARK NJ : 07102-3121
stock-summary
Tel: 1 973 4381000
stock-summary
Registrar Details